Form 8-K - Current report:
SEC Accession No. 0001104659-04-029734
Filing Date
2004-10-05
Accepted
2004-10-05 16:37:47
Documents
7
Period of Report
2004-09-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a04-11245_18k.htm 8-K 37268
2 EX-10.1 a04-11245_1ex10d1.htm EX-10.1 24126
3 EX-10.2 a04-11245_1ex10d2.htm EX-10.2 53063
4 EX-10.3 a04-11245_1ex10d3.htm EX-10.3 37782
5 EX-10.4 a04-11245_1ex10d4.htm EX-10.4 33104
6 EX-99.1 a04-11245_1ex99d1.htm EX-99.1 14549
7 GRAPHIC g112451mmimage002.jpg GRAPHIC 4545
  Complete submission text file 0001104659-04-029734.txt   206977
Mailing Address 236 WEST CUMMINGS PARK WOBURN MA 01801
Business Address 236 WEST CUMMINGS PARK WOBURN MA 01801 6179326616
ANIKA THERAPEUTICS INC (Filer) CIK: 0000898437 (see all company filings)

EIN.: 043145961 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14027 | Film No.: 041066409
SIC: 2836 Biological Products, (No Diagnostic Substances)